jborza

Home>Admin

About Admin

This author has not yet filled in any details.
So far Admin has created 25 blog entries.
Oct 19 2020

Arizona State University/Halberd Initiate Patent Application for Unique New Engineered Class of Covid-19 Antibody

By |2020-10-19T07:29:06-04:00October 19th, 2020|Featured, Investor News, News|0 Comments

Jackson Center, PA, October 19, 2020 – Halberd Corporation (OTC PINK: "HALB") today announced the creation of a new class of anti-Spike protein monoclonal antibodies against Covid-19.  The discovery is the result of Halberd’s research in conjunction with Arizona State University’s Dr. Qiang “Shawn” Chen, utilizing Halberd’s intellectual property created by Mitchel S. Felder, MD.  ...

Oct 13 2020

Arizona State University/Halberd Develop Antibody Against Covid-19

By |2020-10-12T20:32:43-04:00October 13th, 2020|Featured, Investor News, News|0 Comments

Jackson Center, PA, October 13, 2020 – Halberd Corporation (OTC PINK: "HALB") reported that Arizona State University researchers, utilizing the intellectual property of Halberd Corporation, have successfully generated an anti-Spike protein monoclonal antibody against Covid-19.  The Spike Protein is a main component of the Covid-19 virus, and is a crucial component in its ability to replicate.  ...

Oct 8 2020

Halberd Corporation CEO Update Letter – October, 2020

By |2020-10-07T19:53:21-04:00October 8th, 2020|Featured, Investor News|0 Comments

Greetings From The CEO And Staff At Halberd Corporation! (OTC-PINK: HALB) This initial CEO Letter reflects a summary of major accomplishments since I began my tenure at Halberd Corporation.  Going forward, I intend to provide update letters to our shareholders and the public on a quarterly basis. A LOOK BACK Since I began at Halberd ...

Oct 1 2020

Halberd COVID-19 Preventative Nasal Spray Provisional Patent Application Filed

By |2020-09-30T20:26:49-04:00October 1st, 2020|Featured, Investor News, News|0 Comments

Jackson Center, PA, October 1, 2020 – Halberd Corporation (OTC-PINK: "HALB") announced they have obtained world-wide license to a provisional patent application covering a nasal spray to be used as a prevention measure against coronavirus.  The provisional patent, “Nasal Spray To Prevent The Transmission Of Covid-19 Between Humans,” was filed recently with the U.S. Patent ...

Sep 28 2020

Arizona State University/Halberd Pursue Nasal Spray As Covid-19 Preventative/Treatment Based On Children’s Natural Immunity

By |2020-09-27T19:42:54-04:00September 28th, 2020|Featured, Investor News, News|0 Comments

Jackson Center, PA, September 28, 2020 – Children are far less susceptible than adults to the Coronavirus (1, 2).  Halberd Corporation’s (OTC PINK: "HALB") scientists have determined the reason may be that adults have far more Angiotensin-Converting Enzyme 2 (ACE2) receptors in nasal membrane epithelial cells.  ACE2 (3) is a membrane protein expressed in many ...

Sep 24 2020

Arizona State University/Halberd Corp. Covid-19 R&D Program Rapid Diagnostic Test / Treatment

By |2020-09-23T20:35:03-04:00September 24th, 2020|Featured, Investor News, News|0 Comments

Jackson Center, PA, September 24, 2020 – Halberd Corporation (OTC PINK: "HALB") clarifies next steps in their unique research with Arizona State University.  Halberd directed their research program to focus on that element of Covid-19 which makes the disease most contagious -- the spike antigen. ASU investigators have projected the production of the coronavirus spike ...

Sep 21 2020

Arizona State University/Halberd Corp. Covid-19 Research Program Progress – Successful Covid Spike Protein Disease Antigen Re-Creation!

By |2020-09-20T20:34:28-04:00September 21st, 2020|Featured, Investor News, News|0 Comments

Jackson Center, PA, September 21, 2020 – Halberd Corporation (OTC PINK: "HALB") released a progress update on the research being conducted in conjunction with Arizona State University researchers.  Dr. Qiang Chen, ASU’s lead researcher, reports the successful re-creation of the coronavirus spike protein disease antigen in laboratory research. With this breakthrough, Dr. Chen’s team will ...

Sep 17 2020

Arizona State University/Halberd Corp. Outline Partnership 2nd Stage Goals of $1.4 M Covid-19 Program

By |2020-09-17T08:26:31-04:00September 17th, 2020|Featured, Investor News, News|0 Comments

Jackson Center, PA, September 17, 2020 – Halberd Corporation (OTC PINK: "HALB") today outlined the specifics of the second stage goals of the $1.4 Million seven-phase research project with Arizona State University. The second stage of the research involves an investigation of a method using dialysis, or a variant of dialysis, to remove the fluorescent ...

Sep 14 2020

Halberd Corporation Outlines Multi-Phase $1.4 M Covid-19 Program in Partnership With ASU

By |2020-09-13T20:36:48-04:00September 14th, 2020|Featured, Investor News, News|0 Comments

Jackson Center, PA, September 14, 2020 – Halberd Corporation (OTC PINK: "HALB") today released the specifics of the initial phase of the $1.4 Million seven-phase research project with Arizona State University. The University project for a rapid test to identify Covid-19 infection, from a sample such as saliva, mucus, blood and CSF will be based ...

Sep 8 2020

Halberd Corporation Research on Covid-19 Treatment Development Begins at ASU

By |2020-09-08T11:19:17-04:00September 8th, 2020|Featured, Investor News, News|0 Comments

Jackson Center, PA, September 8, 2020 – Halberd Corporation (OTC PINK: "HALB") today announced Arizona State University (ASU) commenced its research work for Halberd Corp. The initial phases of ASU’s research focuses on the development of antibodies in support of Halberd’s two issued patents and three Covid-19 related provisional patent applications for extracorporeal removal of ...

Go to Top